Eriodictyol downregulates UBA52 to promote autophagy and upregulates Nrf2/HO-1 to inhibit oxidative stress to ameliorate non-alcoholic fatty liver disease
Journal of Functional Foods · 2024-02 · 113 · 106041
DOI: 10.1016/j.jff.2024.106041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Functional Foods, 2024-02. Verfasst von Yongqing Cai und 11 weiteren Autor:innen. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Chongqing Municipality, Chongqing Municipal Health and Family Planning Commission.
Abstract (Originalsprache)
Eriodictyol (Eri) is a widely distributed flavonoid compound. We explored the effect of Eri on non-alcoholic fatty liver disease (NAFLD) and the underlying mechanism. Eri reduced hepatic lipid accumulation and alanine aminotransferase, aspartate aminotransferase, cholesterol, and triglyceride levels in high-fat diet-induced NAFLD mice. Proteomics analysis showed that Eri regulated oxidative stress- and autophagy-related signaling pathways. Eri treatment upregulated MAP1LC3 (LC3)II/I, nuclear factor E2-related factor (Nrf2), and heme oxygenase 1 (HO-1), downregulated Ubiquitin A-52 residue ribosomal protein fusion product 1 (UBA52) and SQSTM1 (p62), inhibited p-nuclear factor-κB (p-NF-κB), and reduced tumor necrosis factor-α (TNF-α) and interleukin 6 (IL-6) release. UBA52 knockdown or Eri treatment promoted autophagy in oil acid-induced HepG2 cells. UBA52 knockdown combined with Eri treatment produced a more prominent effect than either of the treatments alone. Eri also significantly ameliorated hepatic lipid accumulation in db/db mice. Thus, Eri ameliorated NAFLD by downregulating UBA52 to promote autophagy and activated Nrf2/HO-1 to inhibit oxidative stress. Eri might be a potential compound for treating NAFLD.
Förderung
- Natural Science Foundation of Chongqing Municipality
- Chongqing Municipal Health and Family Planning Commission
Zitieren
APA
Cai, Y., Yuan, L., Wang, K., Liu, Q., Xing, H., Zhong, P., Lin, J., Liang, Y., Chen, G., Li, W., Chen, J., & Li, X. (2024). Eriodictyol downregulates UBA52 to promote autophagy and upregulates Nrf2/HO-1 to inhibit oxidative stress to ameliorate non-alcoholic fatty liver disease. Journal of Functional Foods, 113, 106041. https://doi.org/10.1016/j.jff.2024.106041
Vancouver
Cai Y, Yuan L, Wang K, Liu Q, Xing H, Zhong P, et al. Eriodictyol downregulates UBA52 to promote autophagy and upregulates Nrf2/HO-1 to inhibit oxidative stress to ameliorate non-alcoholic fatty liver disease. Journal of Functional Foods. 2024;113:106041. doi:10.1016/j.jff.2024.106041
BibTeX
@article{Cai2024,
author = {Cai, Yongqing and Yuan, Lie and Wang, Kaiyang and Liu, Qinglong and Xing, Haiyan and Zhong, Peiling and Lin, Jinjian and Liang, Yuan and Chen, Gefei and Li, Wenjun and Chen, Jianhong and Li, Xiaoli},
title = {Eriodictyol downregulates UBA52 to promote autophagy and upregulates Nrf2/HO-1 to inhibit oxidative stress to ameliorate non-alcoholic fatty liver disease},
journal = {Journal of Functional Foods},
year = {2024},
volume = {113},
pages = {106041},
doi = {10.1016/j.jff.2024.106041}
}
EUVIMED